Concepedia

Publication | Open Access

Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford

DOIFull Paper Access

21

Citations

20

References

2020

Year

Samba Siva Reddy Pulusu, Ashish Srinivasan, Krupa Krishnaprasad, Jakob Begun, Charlotte Keung, Daniel R. van Langenberg, Lena Thin, Tamara Mogilevski, Peter De Cruz, Graham Radford‐Smith,
World Journal of Gastroenterology

Abstract

VDZ was safe and effective with 60% of UC patients achieving clinical remission at 12 mo and prior anti-TNF exposure influenced this outcome.

References

YearCitations

Page 1